Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “urokinase”

8 pharma patents match "urokinase" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 8
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 8 pharmaceutical patents matching "urokinase" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

8 results for “urokinase” · 30,257 patents in full index Clear search

  1. US 12331334

    Modified urokinase-type plasminogen activator polypeptides and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted

  2. US 11613744

    Modified urokinase-type plasminogen activator polypeptides and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  3. US 10239954

    Antibodies specific for urokinase-type plasminogen activator and methods of use thereof for treating cancer

    The Regents of the University of California · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  4. US 9695249

    Antibodies specific for urokinase-type plasminogen activator and methods of use thereof

    The Regents of the University of California · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted

  5. US 9255155

    Antibodies specific for urokinase-type plasminogen activator and methods of treating cancer

    The Regents of the University of California · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted

  6. US 9029509

    Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen activator receptor (uPAR)

    The Regents of the University of California · Granted May 12, 2015 · Expires May 7, 2035

    granted

  7. US 8546322

    Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof

    The Regents of the University of California · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  8. US 7332469

    Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions

    The Board of Regents of the University of Texas System · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.